Debra Griffin
Payments from drug & device makers
Across 238 payments — averaging $16.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Amgen$611
- GSK$517
- Novo Nordisk$422
- Novartis$415
- Boston Scientific$130
- plus $712 from 14 others
What the payments were for
- Food & beverage$4,020100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 47 | $1,214 |
| Amgen(2 entities) | 49 | $611 |
| GSK | 49 | $517 |
| Novo Nordisk | 21 | $422 |
| Novartis | 31 | $415 |
| Boston Scientific | 1 | $130 |
| Daiichi Sankyo Inc. | 5 | $94 |
| Pfizer | 5 | $90 |
| Exact Sciences | 5 | $85 |
| Phathom Pharmaceuticals, Inc. | 5 | $74 |
| Lilly USA, LLC | 4 | $65 |
| AbbVie | 3 | $62 |
| Mylan Specialty L.p. | 3 | $51 |
| Bayer | 3 | $50 |
| Dexcom, Inc. | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Johnson & Johnson | 1 | $24 |
| Itamar Medical Inc | 1 | $17 |
| Boehringer Ingelheim | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$219
- WATCHMAN FLX$130
- RYBELSUS$125
- Saxenda$124
- BREZTRI$116
How this compares
$4,020 in reported general payments places this provider in the 90th percentile of 4,941 family providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 93 | $99,357 |
| EliquisApixaban | 63 | $80,325 |
| JanuviaSitagliptin Phosphate | 56 | $56,390 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 45 | $41,373 |
| JardianceEmpagliflozin | 27 | $33,505 |
| RybelsusSemaglutide | 18 | $31,653 |
| XareltoRivaroxaban | 32 | $28,461 |
| OzempicSemaglutide | 27 | $25,757 |
| TrulicityDulaglutide | 13 | $14,503 |
| EntrestoSacubitril/Valsartan | 17 | $14,357 |
| InvokanaCanagliflozin | 12 | $7,014 |
| SynthroidLevothyroxine Sodium | 53 | $6,061 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $3,754 |
| Ibandronate Sodium | 91 | $3,273 |
| Atorvastatin Calcium | 401 | $2,996 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $65 | $113,860106 claims |
| PfizerEliquis | $90 | $80,32563 claims |
| Novo NordiskRybelsus, Ozempic | $422 | $57,41045 claims |
| GSKTrelegy Ellipta, Shingrix | $517 | $43,94957 claims |
| Johnson & JohnsonXarelto, Invokana | $24 | $35,47544 claims |
| Boehringer IngelheimJardiance | $14 | $33,50527 claims |
| NovartisEntresto | $415 | $14,35717 claims |
| AbbVieSynthroid | $62 | $6,06153 claims |
| AstraZenecaSymbicort | $1,214 | $3,75411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,941 family providers in Illinois.
Other family in Paris
- Ruth CarricoChicago$582K
- Aleksandra BielawiecBarrington$373K
- Erin SieberNaperville$334K
- Jamie BroganChicago$282K
- Ashley NoethGlen Carbon$271K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Brooke KennardBloomington$208K
- Amy BrownellElk Grove Village$202K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.